Research map: Clinical Impact of Germline Pathogenic Variants in High-risk Prostate Cancer Treated with Radiotherapy

Back to the article

Papers in this map

  1. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Sue M. Richards · 2015 · 33500 citations · Cited by this paper
  2. Autologous transobturator sling: From mesh to human tissue. A case report · 2026 · Related
  3. Olaparib for Metastatic Castration-Resistant Prostate Cancer · Johann Sebastian De Bono · 2020 · 2327 citations · Cited by this paper
  4. Irreversible bladder damage after intravesical BCG therapy requiring radical cystectomy: A case report · 2026 · Related
  5. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer · Colin C. Pritchard · 2016 · 1704 citations · Cited by this paper
  6. Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy · 2026 · Related
  7. The Lancet Commission on prostate cancer: planning for the surge in cases · Nicholas David James · 2024 · 726 citations · Cited by this paper
  8. Urethral necrosis after catheterization in a patient with an artificial urinary sphincter: Why physical examination and appropriate drainage matter · 2026 · Related
  9. CHEK2 Is a Multiorgan Cancer Susceptibility Gene · Cezary Cybulski · 2004 · 560 citations · Cited by this paper
  10. Propensity score–matched comparison of radical prostatectomy with versus without pelvic lymph node dissection in high-risk prostate cancer patients · 2026 · Related
  11. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients · The UKGPCS Collaborators · 2011 · 406 citations · Cited by this paper
  12. Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study · 2026 · Related
  13. Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer · Elena Castro · 2014 · 376 citations · Cited by this paper
  14. DEEP-URO RA/LP: DE-Escalation of antibiotic Prophylaxis in UROlogical procedures in Robot-Assisted or Laparoscopic Prostatectomy · 2026 · Related
  15. Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene · Stephen M. Edwards · 2003 · 367 citations · Cited by this paper
  16. Fluid dynamics in penile Doppler ultrasound: Cavernosal Kinetic Energy Index (CKEI) vs. Resistive Index (RI) for erection hardness · 2026 · Related
  17. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1 · Laura Fachal · 2014 · 151 citations · Cited by this paper
  18. Prognostic value of seven urinary tissue proteomic biomarkers in prostate cancer · 2026 · Related
  19. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing · Veda N. Giri · 2018 · 114 citations · Cited by this paper
  20. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study · Questa Karlsson · 2021 · 79 citations · Cited by this paper
  21. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors · Saud H. AlDubayan · 2019 · 76 citations · Cited by this paper
  22. Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy · Kenneth L. Pitter · 2020 · 70 citations · Cited by this paper
  23. The influence of BRCA2 mutation on localized prostate cancer · Renea A. Taylor · 2019 · 69 citations · Cited by this paper
  24. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer · Burcu F. Darst · 2023 · 57 citations · Cited by this paper
  25. Diagnosing hereditary cancer predisposition in men with prostate cancer · Mary Pritzlaff · 2020 · 47 citations · Cited by this paper
  26. PARP inhibitors combined with radiotherapy: are we ready? · Chen Sun · 2023 · 47 citations · Cited by this paper
  27. Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM · Jennifer Ma · 2016 · 45 citations · Cited by this paper
  28. Clinical Applications of Molecular Biomarkers in Prostate Cancer · Felipe Couñago · 2020 · 42 citations · Cited by this paper
  29. Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer · Amar Upadhyaya Kishan · 2020 · 27 citations · Cited by this paper
  30. Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants · Ryan J. Stubbins · 2025 · 17 citations · Cited by this paper
  31. Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases · Jonathan Mitchell · 2025 · 16 citations · Cited by this paper
  32. Molecular correlates of intermediate- and high-risk localized prostate cancer · Huihui Ye · 2018 · 10 citations · Cited by this paper
  33. Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer · Benjamin Louis Maughan · 2021 · 10 citations · Cited by this paper
  34. Which patients with localized prostate cancer account for the greatest proportion of prostate cancer deaths? · Michelle Daniel Nezolosky · 2018 · 9 citations · Cited by this paper
  35. Untitled · Cited by this paper
  36. Untitled · Cited by this paper

Source: OpenAlex (CC0)